Availability: In Stock

Cervical Cancer: Methods and Protocols (Methods in Molecular Biology)

SKU: 9781493920129

Original price was: $40.00.Current price is: $7.00.

Cervical Cancer: Methods and Protocols (Methods in Molecular Biology), Nikhil C. Munshi, 9781493920129

Description

Representing the most relevant procedures and technologies aiding the advance of the field of HPV-mediated carcinogenesis of the cervix and other anatomical regions of squamocolumnar transition, such as the anorectum, penis, and oropharynx, Cervical Cancer: Methods and Protocols compiles a detailed collection of practical chapters. The first half of the book covers HPV types, pathogenesis of cervical cancer (CxCA), prevention, and novel potential drug targets, while the second half explores pathology, genomics, modeling of CxCA, and experimental therapeutic strategies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and vital, Cervical Cancer: Methods and Protocols serves as a valuable resource to both bench scientists and clinicians who step into the realm of high-risk HPVs and CxCA for the first time or those who wish to learn novel approaches or expand their toolbox for the study of CxCA. Part I: Approaches to the Detection and Analysis of HPV Types   1. Evolution and Classification of Oncogenic Human Papillomavirus Types and Variants Associated with Cervical Cancer             Zigui Chen, Luciana Bueno de Freitas, and Robert D. Burk   2. A Real-Time PCR Approach Based on SPF10 Primers and the INNO-LiPA HPV Genotyping Extra Assay for the Detection and Typing of Human Papillomavirus             M. Isabel Micalessi, Gaelle A. Boulet, and J. Jean-Paul Bogers   Part II: Molecular Pathogenesis of CxCA   3. Replication of Human Papillomavirus in Culture             Eric J. Ryndock, Jennifer Biryukov, and Craig Meyers   4. HPV Binding Assay to Laminin-332/Integrin a64 on Human Keratinocytes             Sarah A. Brendle and Neil D. Christensen   5. Methods to Assess the Nucleocytoplasmic Shuttling of the HPV E1 Helicase and Its Effects on Cellular Proliferation and Induction of a DNA Damage Response             Michal Lehoux, Amlie Fradet-Turcotte, and Jacques Archambault   6. Genetic Methods for Studying the Role of Viral Oncogenes in the HPV Life Cycle             Jason M. Bodily   7. Robust HPV-18 Production in Organotypic Cultures of Primary Human Keratinocytes             Hsu-Kun Wang, Thomas R. Broker, and Louise T. Chow   8. A High-Throughput Cellular Assay to Quantify the p53-Degradation Activity of E6 from Different Human Papillomavirus Types             David Gagnon and Jacques Archambault   9. Retroviral Expression of Human Cystatin Genes in HeLa Cells             Crystal M. Diep, Gagandeep Kaur, Daniel Keppler, and Athena W. Lin   Part III: Vaccinations and Immune Responses to HPV Infections   10. Molecular Analysis of Human Papillomavirus Virus-Like Particle Activated Langerhans Cells In Vitro             Andrew W. Woodham, Adam B. Raff, Diane M. Da Silva, and W. Martin Kast   Part IV: Identification of Novel Potential Drug Targets   11. Selective Silencing of Gene Target Expression By siRNA Expression Plasmids in Human Cervical Cancer Cells             Peralta-Zaragoza Oscar, De la O-Gmez Faustino, Deas Jessica, Fernndez-Tilapa Gloria, Fierros-Zrate Geny del Socorro, Gmez-Cern Claudia, Burguete-Garca Ana, Torres-Poveda Kirvis, Bermdez-Morales Victor Hugo, Rodrguez-Dorantes Mauricio, Prez-Plasencia Carlos, and Madrid-Marina Vicente   12. Silencing of E6/E7 Expression in Cervical Cancer Stem-Like Cells             Wenyi Gu, Nigel McMillan, and Chengzhong Yu   13. Two-Step Procedure for Evaluating Experimentally Induced DNA Damage: Texas Red and Comet Assays             Gina J. Ferris, Lauren B. Shunkwiler, and Charles A. Kunos   14. Measurement of Deubiquitinating Enzyme Activity Via a Suicidal HA-Ub-VS Probe             Colleen Rivard and Martina Bazzaro   Part V: Approaches to Detecting, Typing, and Staging of CxCA   15. Immunocytochemical Analysis of the Cervical Pap Smear             Terry K. Morgan and Michelle Berlin   16. Diagnosis of HPV-Negative, Gastric-Type Adenocarcinoma of the Endocervix             Edyta C. Pirog   17. Targeting of the HPV-16 E7 Protein by RNA Aptamers             Julia Dolores Toscano-Garibay, Mara Luisa Bentez-Hess, and Luis Marat Alvarez-Salas   18. The Use of MYBL2 as a Novel Candidate Biomarker of Cervical Cancer             Cara M. Martin, Katharine Astbury, Louise Kehoe, Jacqueline Barry O’Crowley, Sharon O’Toole, and John J. O’Leary   19. Fixation Methods for the Preservation of Morphology, RNAs, and Proteins in Paraffin-Embedded Human Cervical Cancer Cell Xenografts in Mice             Yoko Matsuda and Toshiyuki Ishiwata   Part VI: Genomic Analyses of CxCA   20. Assessment of the HPV DNA Methylation Status in Cervical Lesions             Mina Kalantari and Hans-Ulrich Bernard   21. MeDIP-on-Chip for Methylation Profiling             Yaw-Wen Hsu, Rui-Lan Huang, and Hung-Cheng Lai   22. Use of DBD-FISH for the Study of Cervical Cancer Progression             Eva I. Corts-Gutirrez, Jose L. Fernndez, Martha I. Dvila-Rodrguez, Carmen Lpez-Fernndez, and Jaime Goslvez   Part VII: Cellular Assays and Cell Culture Models of CxCA   23. A Quantitative and High-Throughput Assay of Human Papillomavirus DNA Replication             David Gagnon, Amlie Fradet-Turcotte, and Jacques Archambault   24. Native Human Papillomavirus Production, Quantification, and Infectivity Analysis             Jennifer Biryukov, Linda Cruz, Eric J. Ryndock, and Craig Meyers   25. Functional Analysis of HPV-Like Particle-Activated Langerhans Cells In Vitro             Lisa Yan, Andrew W. Woodham, Diane M. Da Silva, and W. Martin Kast   26. Assessment of the Radiation Sensitivity of Cervical Cancer Cell Lines             Mayil Vahanan Bose and Thangarajan Rajkumar   Part VIII: Animal Models of CxCA and Experimental Therapeutic Strategies   27. Mouse Model of Cervicovaginal Papillomavirus Infection             Nicolas uburu, Rebecca J. Cerio, Cynthia D. Thompson, and Patricia M. Day   28. Establishment of Orthotopic Primary Cervix Cancer Xenografts             Naz Chaudary, Karolina Jaluba, Melania Pintilie, and Richard P. Hill   29. Generation of K14-E7/N87cat Double Transgenic Mice as a Model of Cervical Cancer             Glay Blt and Aykut ren

Additional information

Publisher

ISBN

Date of Publishing

Author

Category

Page Number